Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 12/20 | 0.47 |
| ▸ | MAP3K12 | Q12852 | 4/20 | 0.44 |
| ▸ | THRB | P10828 | 3/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL625621 | 0.90 | MAP3K12 (0.46) | MAPTMAP3K12PIK3CA | |
| SCHEMBL626106 | 0.89 | THRB (0.49) | MAPTTHRBGAAPIK3CA | |
| SCHEMBL627411 | 0.89 | MAP3K12 (0.47) | MAPTMAP3K12PIK3CA | |
| SCHEMBL624412 | 0.86 | MAP3K12 (0.45) | MAPTMAP3K12PIK3CA | |
| SCHEMBL627373 | 0.85 | MAP3K12 (0.46) | MAPTMAP3K12THRBPIK3CA | |
| SCHEMBL626463 | 0.85 | PIK3CA (0.53) | LMNAL3MBTL1PIK3CA | |
| SCHEMBL625228 | 0.85 | MAP3K12 (0.46) | MAP3K12PIK3CA | |
| SCHEMBL625223 | 0.84 | MAPT (0.49) | MAPTTHRBLMNA | |
| SCHEMBL624389 | 0.84 | MAP3K12 (0.43) | MAP3K12PIK3CA | |
| SCHEMBL624968 | 0.83 | MAP3K12 (0.43) | MAPTMAP3K12THRBGAAPIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012020215-A1 | AMINO- IMIDAZOLOTHIADIAZOLES FOR USE AS PROTEIN OR LIPID KINASE INHIBITORS | CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) | 2012-02-16 | — | — | WO | disclosed |